Press release from Mallinckrodt Licenses Inhaled Xenon Gas Therapy Development Product
Sem títuloPress release from Neuroprotexeon on the European Distribution Partnership between NeuroproteXeon and Linde
Sem títuloResults from the Phase 1 Trials - Feasibility and safety of delivering xenon to patients undergoing coronary artery bypass graft surgery while on cardiopulmonary bypass: phase I study
Moderate hypothermia within 6 h of birth plus inhaled xenon versus moderate hypothermia alone after birth asphyxia (TOBY-Xe): a proof-of-concept, open-label, randomised controlled trial
Award of EU-FP7 funding to Alkion BioPharma as part of TriForC consortium working on the commercialization of terpenoids
Sem títuloStudy which highlighted that Bd had been introduced into Mallorca
Report examining the likelihood of meeting the World Health Organization’s (WHO) guideline levels for air pollution (PM2.5) in the UK by 2030.
Sem títuloPASTA outputs were cited within this document
Report on Climate Change by the High Council on Climate of France. Cites the IPCC report and need for net zero carbon by 2050 to limit warming to 1.5 deg
Sem títuloHansard from the Lords debate on invasive species regulation citing research in debated
Sem títuloebook on the complicance of a integrated systems approach for pest risk management
Sem títuloCreating resilient value chains for small holder farmers. Chapter 5 in Africa Agriculture Status Report.
Sem título